avian
infecti
bronchiti
ib
wide
distribut
poultri
diseas
huge
econom
impact
poultri
industri
continu
emerg
new
ibv
genotyp
lack
cross
protect
among
differ
ibv
genotyp
import
challeng
although
live
attenu
ib
vaccin
remark
induc
potent
immun
respons
potenti
risk
revers
virul
neutral
matern
antibodi
recombin
mutat
event
import
concern
usag
hand
inactiv
vaccin
induc
weaker
immun
respons
may
requir
multipl
dose
andor
use
adjuv
probabl
potenti
safeti
risk
increas
econom
burden
consequ
altern
ib
vaccin
wide
sought
recent
advanc
recombin
dna
technolog
result
experiment
ib
vaccin
show
promis
antibodi
tcell
respons
compar
live
attenu
vaccin
recombin
dna
vaccin
also
enhanc
target
multipl
serotyp
efficaci
improv
use
deliveri
vector
nanoadjuv
ovo
vaccin
approach
although
recombin
ib
dna
vaccin
yet
licens
expect
type
vaccin
may
hold
sway
futur
vaccin
induc
cross
protect
multipl
ibv
serotyp
avian
infecti
bronchiti
ib
econom
import
poultri
diseas
affect
respiratori
renal
reproduct
system
chicken
although
ib
first
identifi
north
dakota
usa
epidemiolog
evid
confirm
circul
sever
ibv
serotyp
differ
part
world
current
classic
variant
ibv
serotyp
identifi
countri
thu
make
ib
control
prevent
global
challeng
diseas
associ
huge
econom
loss
result
decreas
egg
product
poor
carcass
weight
high
morbid
mortal
rate
could
high
young
chicken
especi
secondari
complic
viral
bacteri
infect
vaccin
consid
cost
effect
approach
control
ibv
infect
howev
approach
challeng
sever
factor
includ
emerg
new
ibv
serotyp
current
variant
show
littl
cross
protect
importantli
ibv
strain
vaccin
becom
avail
might
disappear
new
variant
emerg
thu
necessit
develop
new
vaccin
recent
ibv
vaccin
base
live
attenu
kill
vaccin
deriv
classic
variant
serotyp
vaccin
develop
strain
origin
usa
ark
conn
netherland
exampl
well
european
strain
howev
studi
shown
vaccin
strain
often
lead
poor
immun
respons
especi
local
strain
live
attenu
ib
vaccin
also
shown
contribut
emerg
new
pathogen
ibv
variant
notabl
chang
geograph
distribut
tissu
tropism
observ
qxlike
strain
initi
emerg
china
spread
caus
great
econom
loss
poultri
farmer
asia
russia
europ
review
aim
describ
progress
challeng
associ
ibv
vaccin
develop
aspect
viralinduc
immun
respons
discuss
beluga
whale
coronaviru
belong
gammacoronaviru
subgroup
famili
coronavirida
order
nidoviral
although
antigen
differ
member
coronavirida
famili
sar
mer
coronaviru
share
common
structur
protein
organis
coronavirus
genom
made
singl
strand
envelop
rna
measur
kb
make
largest
rna
virus
particularli
ibv
genom
averag
diamet
nm
typic
larg
club
nm
heavili
glycosyl
spike
project
four
differ
gene
encod
structur
protein
found
ibv
genom
design
spike
envelop
e
matrix
nucleocapsid
n
structur
protein
gene
also
interspac
gene
code
nonstructur
accessori
protein
arrang
order
direct
utrpoli
structur
protein
gene
n
protein
contain
epitop
respons
host
immun
respons
figur
glycoprotein
sprotein
heavili
glycosyl
transmembran
protein
span
amino
acid
give
rise
kda
possess
cleav
signal
sequenc
one
transmembran
domain
short
ctermin
tail
ibv
sprotein
made
nucleotid
posttransl
cleav
aa
residu
amino
termin
aa
residu
carboxyl
termin
two
glycosyl
protein
anchor
hydrophob
region
near
carboxyl
part
cleav
furin
relat
enzym
golgi
complex
typic
play
role
receptor
bind
contribut
aid
fusion
viru
two
sglycoprotein
gene
import
immunogen
compon
contain
epitop
respons
neutral
antibodi
also
determin
receptor
bind
well
membran
fusion
via
virustocel
celltocel
interact
gene
protein
ibv
genom
possess
two
small
nsp
gene
express
three
e
two
gene
product
respect
protein
ibv
show
uniqu
sequenc
characterist
compar
member
group
ii
coronavirus
although
specif
function
small
protein
remain
unknown
gene
thought
contribut
viru
virul
studi
function
segment
use
revers
genet
identifi
possibl
link
nsprotein
viru
virul
howev
contribut
viru
replic
may
less
relev
protein
coronaviru
matrix
protein
mprotein
slightli
protrud
surfac
situat
aa
glycosyl
ntermin
domain
although
member
group
coronaviru
oglycosyl
ibv
member
group
coronavirus
glycosyl
nlink
oligosaccharid
molecul
role
glycosyl
mprotein
still
clear
howev
use
mhv
model
found
cell
infect
mhv
contain
nglycosyl
mprotein
induc
better
interferon
respons
compar
infect
oglycosyl
mprotein
nonglycosyl
mprotein
mhv
infect
result
poor
interferon
respons
protein
viral
replic
direct
interact
occur
nand
mprotein
similarli
n
similarli
indirect
interact
suggest
n
result
smprotein
segment
interact
nucleocapsid
protein
function
bind
genom
grna
form
helic
ribonucleoprotein
complex
rnpc
thu
aid
transcript
replic
translat
packag
viral
genom
replic
process
coronaviru
nprotein
also
play
role
induct
cytotox
tlymphocyt
respons
due
presenc
ctlinduc
epitop
locat
carboxyl
terminu
addit
novel
linear
bcell
epitop
peptid
map
within
nucleocapsid
ntermin
domain
small
envelop
protein
ibv
small
envelop
e
protein
scant
protein
contain
highli
hydrophob
transmembran
ntermin
cytoplasm
ctermin
domain
protein
suggest
associ
viral
envelop
format
assembl
bud
ion
channel
activ
apoptosi
current
sever
classic
variant
ibv
strain
spread
differ
countri
strain
may
close
distantli
relat
repres
phylogenet
tree
figur
variat
may
aris
due
small
chang
littl
amino
acid
composit
may
lead
alter
cross
protect
among
close
relat
serotyp
thu
natur
sequenc
taken
consider
design
novel
control
strategi
despit
first
identifi
usa
classic
serotyp
dutch
serotyp
wide
use
vaccin
virus
howev
world
organ
anim
health
oie
recommend
distribut
ibv
serotyp
influenc
choic
vaccin
use
geograph
region
exampl
arkansa
connecticut
common
usa
predomin
found
europ
recent
chines
qx
variant
emerg
caus
outbreak
europ
asia
middl
east
africa
demonstr
shift
geograph
distribut
import
qxlike
genotyp
variat
strain
distribut
inde
challeng
ibv
control
programm
expect
serotyp
continu
emerg
result
rna
mutat
recombin
lead
viral
select
pressur
local
variant
common
within
specif
region
andor
countri
global
distribut
yet
ascertain
figur
neighbourjoin
phylogenet
show
relationship
classic
pink
variant
blue
ibv
strain
tree
reliabl
assess
use
confid
branch
pattern
support
bootstrap
valu
associ
taxa
show
pairwis
ident
phylogenet
analysi
carri
use
geneiou
softwar
version
viral
genom
rna
virus
mutat
recombin
two
import
event
alter
shape
coronaviru
viral
genom
consequ
viral
subpopul
may
evolv
result
import
genet
event
although
difficult
ascertain
ibv
genom
evolv
three
major
theori
hypothesis
follow
lack
rna
polymeras
proofread
activ
could
lead
error
rna
genom
turn
result
mutat
especi
spike
gene
nucleotid
insert
delet
point
mutat
ii
use
vaccin
especi
live
attenu
vaccin
type
presenc
multipl
infect
differ
ibv
serotyp
contribut
recombin
process
favour
emerg
new
ibv
variant
mixtur
variou
genet
mutant
coronaviru
strain
shown
gener
quasispeci
virus
mutat
hypervari
domain
may
affect
viral
subpopul
result
new
virus
differ
pathogen
well
virul
found
region
encod
nonstructur
protein
well
spike
glycoprotein
exhibit
highest
degre
recombin
likewis
experiment
passag
ibv
presenc
immunosuppress
virus
marek
diseas
viru
chicken
anaemia
viru
infecti
bursal
diseas
suggest
affect
ibv
evolutionari
dynam
matern
deriv
antibodi
mda
import
compon
earli
protect
infecti
agent
shown
mda
last
day
week
depend
viru
strain
approxim
bird
mda
like
protect
ibv
infect
day
one
age
howev
protect
may
declin
age
day
thu
demonstr
limit
durat
protect
adopt
transfer
antibodi
also
report
induc
associ
tlymphocyt
protect
chicken
infect
virul
ibv
strain
thu
signifi
role
passiv
immun
ibv
infect
innat
immun
respons
import
bodi
first
line
defenc
respons
reli
pathogenassoci
molecular
pattern
pamp
specif
patternrecognit
receptor
prr
display
immun
cell
dendrit
cell
macrophag
lymphocyt
sever
nonimmun
cell
endotheli
cell
mucos
cell
fibroblast
importantli
type
interferon
respons
character
secret
chicken
interferon
alpha
interferon
beta
provid
effici
rapid
respons
viral
replic
activ
macrophag
natur
killer
cell
lead
induct
adapt
immun
respons
type
ii
interferon
respons
character
interferon
gamma
secret
predominantli
produc
activ
nk
cell
dendrit
cell
tlymphocyt
enhanc
leukocyt
adhes
caus
nk
cell
activ
increas
antigen
present
surfac
apc
macrophag
dendrit
cell
subsequ
caus
express
mhci
molecul
develop
adapt
respons
specif
tolllik
receptor
tlr
involv
innat
sens
viral
infect
sar
viru
mous
hepat
viru
mhv
signific
upregul
observ
ibv
infect
suggest
role
coronaviru
infect
irrespect
host
speci
involv
ibv
infect
innat
immun
respons
associ
secret
type
interferon
trachea
lung
kidney
shortli
contact
viru
respons
howev
depend
virul
ibv
well
host
adapt
viral
strain
chicken
type
interferon
play
import
role
inhibit
viral
replic
probabl
interact
tlr
molecul
patternrecognit
receptor
ppr
crucial
detect
viral
entri
cell
bridg
innat
adapt
immun
respons
support
alter
tlr
express
especi
observ
trachea
lung
kidney
follow
ibv
infect
administr
synthet
oligodeoxynucleotid
cpg
odn
led
signific
increas
express
interferon
gamma
ifngamma
interleukin
oligoadenyl
synthetas
similarli
transcript
analysi
cytokin
profil
reveal
ifn
signal
pathway
may
serv
bridg
innat
adapt
immun
follow
ibv
vaccin
mechan
ibv
induc
antivir
respons
complex
howev
suggest
involv
jakstat
pathway
upregul
gene
relat
immun
respons
crucial
host
immun
respons
wherea
upregul
gene
relat
viral
protein
synthesi
help
viru
evad
immun
defenc
humor
immun
respons
associ
inhibit
viral
replic
shown
correl
ibvspecif
antibodi
titr
antibodi
respons
follow
ibv
vaccin
demonstr
serum
tracheal
swab
lacrim
secret
studi
shown
system
igm
igg
mucos
iga
antibodi
essenti
determin
effect
clearanc
circul
viru
addit
iga
major
immunoglobulin
molecul
mucos
respons
play
role
antibodi
home
tracheal
mucos
point
viral
entri
remark
igm
appear
day
infect
dpi
peak
day
disappear
around
day
infect
local
respons
correl
increas
igg
level
subsequ
clearanc
viru
respons
ngene
specif
protein
respons
associ
induct
ctl
respons
clearanc
ibvinfect
cell
ctl
respons
peak
day
correl
decreas
clinic
sign
viral
clearanc
lung
signific
increas
tcell
report
follow
vaccin
specif
ibv
vaccin
thu
importantli
play
role
cellmedi
immun
respons
viral
clearanc
may
associ
increas
express
granzym
primari
ibv
infect
subsequ
activ
nk
cell
aid
direct
target
kill
ibvinfect
cell
despit
advanc
understand
mucos
immunolog
much
yet
learn
mucos
immun
respons
bird
ibv
replic
harderian
gland
hg
conjunctiva
influenc
develop
mucos
immun
respons
character
secretionsproduct
specif
iga
respons
link
lymphoid
expans
head
associ
lymphoid
tissu
halt
subsequ
induct
ctl
respons
ocular
vaccin
chicken
recombin
nucleocapsid
protein
rn
recombin
rs
base
ibv
vaccin
via
eye
drop
induc
signific
cellmedi
immun
respons
without
booster
vaccin
adjuv
bird
vaccin
vaccin
shown
protect
infect
virul
viru
strain
though
level
iga
mucosa
higher
posit
control
bird
receiv
live
attenu
vaccin
live
attenu
ib
vaccin
first
gener
ibv
vaccin
use
control
ibv
infect
field
vaccin
commerci
avail
applic
via
drink
water
coars
spray
day
within
first
week
age
sinc
durat
immun
follow
live
attenu
vaccin
short
booster
vaccin
carri
combin
strain
week
prime
vaccin
commerci
avail
live
attenu
vaccin
deriv
virul
strain
massachusettsbas
serotyp
dutch
strain
although
strain
region
local
impact
use
differ
part
world
live
vaccin
often
use
broiler
booster
breeder
howev
variat
may
exist
among
countri
type
ibv
vaccin
strain
approv
use
guid
epidemiolog
knowledg
local
region
preval
strain
exampl
usa
arkansa
delawar
florida
jmkderiv
vaccin
use
frequent
australia
b
c
strain
use
ukeurop
vaccin
strain
includ
netherland
vaccin
use
commonli
practic
logist
econom
reason
commerci
avail
live
attenu
ibv
vaccin
combin
viru
vaccin
newcastl
diseas
viru
marek
diseas
viru
infecti
bursal
diseas
viru
ibdv
howev
clear
whether
combin
may
influenc
immun
respons
combin
antigen
exampl
commerci
avail
live
attenu
vaccin
includ
nobili
msd
anim
health
uk
mass
serotyp
avipro
ib
also
consid
mass
serotyp
base
vaccin
dutch
strain
lohmann
anim
health
germani
nobili
msd
anim
health
uk
gallivac
merial
usa
european
strain
live
attenu
vaccin
poulvac
ib
qx
also
produc
recent
endem
qxlike
ibv
strain
pfizer
franc
limit
live
attenu
viral
vaccin
includ
revers
virul
tissu
damag
interfer
mda
tissu
damag
due
live
vaccin
may
lead
patholog
disord
secondari
bacteri
infect
especi
dayold
chick
evid
shown
despit
effort
reduc
viral
virul
use
passag
produc
ibv
vaccin
respect
vaccin
potenti
caus
consider
patholog
trachea
may
lead
sever
outbreak
field
anoth
limit
live
attenu
ibv
vaccin
potenti
recombin
vaccin
strain
virul
field
strain
lead
emerg
new
ibv
serotyp
one
studi
vaccin
live
attenu
vaccin
shown
encourag
viral
spread
among
broiler
chicken
thu
potenti
support
viru
transmiss
persist
reduc
problem
associ
vaccin
revers
research
explor
option
use
revers
genet
technolog
creat
vaccin
viru
potenti
apathogen
host
capabl
replic
induc
immun
respons
shown
case
beaudett
viru
carri
virul
ibv
strain
vaccin
inactiv
kill
vaccin
use
either
alon
combin
live
attenu
ibv
vaccin
vaccin
usual
administ
inject
layer
breeder
week
age
sinc
inactiv
vaccin
replic
unlik
revert
caus
patholog
effect
howev
compar
live
attenu
vaccin
kill
vaccin
alon
induc
shorter
immun
respons
character
antibodi
product
tcellmedi
respons
therefor
inactiv
vaccin
case
requir
prime
live
attenu
vaccin
larg
dose
adjuv
andor
multipl
vaccin
may
increas
cost
associ
vaccin
develop
market
thu
limit
applic
inject
administr
kill
vaccin
either
difficult
impractic
larg
poultri
set
likewis
issu
injectionsit
reaction
may
also
lead
carcass
reject
reduct
valu
vaccin
use
viral
vector
deliv
gene
interest
studi
extens
remark
abil
adenoviru
vector
persist
cell
without
caus
patholog
well
tropism
variou
divid
nondivid
cell
allow
sustain
antigen
releas
also
possibl
packag
express
differ
immunogen
protein
subunit
vectorbas
vaccin
without
necessari
use
whole
virul
organ
experiment
recombin
vector
vaccin
develop
ibv
vaccin
shown
induc
signific
increas
immun
respons
protect
ib
diseas
although
advanc
viral
vector
vaccin
seem
promis
provid
effect
immun
respons
reduc
problem
associ
rna
mutat
seen
live
attenu
ibv
vaccin
technolog
limit
includ
issu
preexist
immun
matern
deriv
immun
interfer
live
vector
reduc
uptak
antigen
antigen
present
cell
consequ
transgen
express
well
specif
immun
respons
lack
proper
protein
fold
glycosyl
host
system
posttransl
modif
may
alter
conform
epitop
arrang
affect
immunogen
efficaci
vaccin
factor
current
given
special
attent
design
select
recombin
ibv
vaccin
recent
studi
use
recombin
adenoviru
vaccin
contain
report
signific
antibodi
respons
confer
protect
tracheal
lesion
follow
homolog
heterolog
challeng
vic
serotyp
b
serotyp
c
ibv
strain
differ
protein
antigen
coexpress
gene
encod
genet
adjuv
enhanc
immun
respons
regard
shi
et
al
show
fowl
pox
viru
vaccin
express
chicken
interferongen
rfpvifn
enhanc
humor
cellmedi
immun
respons
protect
chicken
homolog
heterolog
challeng
lhb
ibv
strain
express
chicken
recombin
fowl
pox
viru
vector
produc
signific
increas
antibodi
titr
respons
similarli
express
use
fowl
pox
viru
vector
result
protect
compar
protect
rate
chicken
receiv
construct
contain
alon
oral
immun
mice
adenoviru
vector
shown
circumv
neutral
vector
preexist
matern
deriv
antibodi
interestingli
adenoviru
vector
vaccin
shown
promis
use
poultri
oral
vaccin
oral
immun
therefor
sever
advantag
poultri
medicin
eas
applic
reduct
stress
associ
inject
handl
although
vectorbas
oral
vaccin
may
lead
adequ
transgen
specif
antibodi
respons
improv
need
optim
tcell
respons
modif
vectorbas
vaccin
dose
escal
nanoparticl
coat
use
dual
vector
eg
combin
pox
adenovirusbas
vector
andor
swap
adenoviru
hexon
gene
attempt
circumv
effect
preexist
immun
degre
success
report
toxic
infect
model
lentiviru
vector
find
way
veterinari
vaccin
although
lentivirusbas
ib
vaccin
uncommon
overal
simultan
compar
studi
assist
understand
advantag
one
vector
other
vaccin
technolog
requir
use
segment
part
viral
protein
induc
specif
immun
respons
subunit
vaccin
deriv
pathogen
protein
polysaccharid
peptid
vaccin
made
pathogen
peptid
portion
genom
code
immunogen
epitop
epitop
within
ngene
target
induct
neutral
antibodi
well
ctl
respons
respect
exampl
studi
demonstr
synthet
epitop
peptid
correspond
react
well
polyclon
antibodi
variou
ibv
strain
thu
demonstr
potenti
applic
broadbas
ib
vaccin
broad
vaccin
also
map
well
aa
sequenc
within
receptor
bind
domain
whose
ntermin
play
role
viral
entri
although
experiment
stage
develop
synthet
peptid
vaccin
shown
promis
control
ibv
research
focus
develop
multiepitop
peptid
vaccin
use
wide
rang
ibv
serotyp
recent
yang
et
al
develop
ibv
vaccin
base
multipl
epitop
nprotein
gene
express
analys
immun
studi
use
design
synthet
peptid
yield
signific
humor
cellmedi
immun
respons
result
protect
challeng
virul
viru
anoth
develop
lactococcu
lacti
bacteri
system
use
deliv
peptid
vaccin
oral
approach
also
report
induc
mucos
immun
respons
unlik
recombin
vectorbas
vaccin
involv
live
vector
dna
vaccin
use
plasmid
contain
gene
code
immunogen
protein
interest
recent
licens
poultri
dna
vaccin
commerci
avail
howev
technolog
gain
consider
attent
sever
product
variou
development
experiment
trial
stage
dna
vaccin
design
develop
base
arkansa
ibv
serotyp
vaccin
via
ovo
rout
follow
immun
live
attenu
vaccin
interv
result
signific
immun
respons
protect
clinic
diseas
hand
bird
receiv
either
ovo
dna
vaccin
alon
live
attenu
vaccin
alon
protect
challeng
virul
ibv
strain
apart
ovo
dna
vaccin
novel
approach
evalu
exampl
intramuscular
inject
liposomeencapsul
multiepitop
dna
vaccin
design
n
region
result
increas
number
cell
protect
immun
respons
immun
bird
advantag
epitopebas
vaccin
includ
abil
packag
sever
immunogen
small
deliveri
system
target
antibodi
ctl
respons
enhanc
vaccineinduc
immun
respons
achiev
coadministr
dna
vaccin
encod
ibv
nucleocapsid
gene
chicken
granulocytemacrophag
stimul
factor
gmcsf
respect
case
signific
increas
humor
cellmedi
immun
respons
report
howev
dna
vaccin
result
better
immun
respons
accord
protect
slightli
higher
compar
ngeneencod
plasmid
anoth
studi
multival
ibvdna
vaccin
encod
n
mprotein
develop
efficaci
protect
capac
gene
specif
ibvdna
vaccin
shown
improv
cation
liposom
carrier
use
similar
result
obtain
boost
inactiv
vaccin
dna
vaccin
limit
includ
rout
administr
sinc
dna
vaccin
administ
inject
thu
make
applic
difficult
larg
commerci
poultri
howev
challeng
relat
rout
dna
vaccin
administr
could
overcom
use
ovo
dna
vaccin
hatcheri
give
vaccin
drink
water
spray
vaccin
nanoparticlemedi
dna
deliveri
assist
protect
vaccin
enzymat
degrad
enhanc
avail
mucos
surfac
mucos
respons
sinc
dna
vaccin
could
use
presenc
matern
antibodi
usag
poultri
could
use
overcom
challeng
associ
vaccin
young
chick
ibv
infect
advantag
dna
vaccin
includ
induct
antibodi
tcell
immun
respons
safeti
abil
express
multipl
protein
thermost
cost
product
could
produc
within
short
period
thu
enabl
handl
emerg
viru
threat
moreov
modif
cytokin
adjuv
favour
choic
control
infecti
diseas
poultri
revers
genet
vaccin
involv
new
technolog
manipul
one
viral
gene
recent
technolog
employ
modifi
ibv
vaccin
candid
exampl
recombin
beauribv
vaccin
construct
recent
substitut
antigen
apathogen
beauibv
strain
anoth
pathogen
european
strain
respect
chang
result
protect
immun
respons
without
make
new
beaur
strain
pathogen
similarli
zhou
et
al
construct
modifi
viru
found
retain
biolog
activ
rescu
passag
embryon
chicken
egg
interestingli
vaccin
use
strain
report
elicit
high
level
haemagglutin
inhibit
hi
antibodi
titr
compar
protect
rate
compar
intact
group
futur
revers
genet
vaccin
may
born
potenti
abrog
issu
revers
virul
report
live
attenu
vaccin
develop
revers
genet
ibv
vaccin
may
overcom
neutral
presenc
preexist
immun
although
difficult
sure
revolutionis
use
revers
geneticbas
live
attenu
ibv
vaccin
whether
newer
gener
vaccin
increas
reduc
chanc
mutat
viral
select
pressur
requir
studi
summari
import
limit
associ
ib
vaccin
present
figur
recombin
subunit
vaccin
consider
given
presenc
absenc
posttransl
modif
associ
vaccin
antigen
howev
thorough
knowledg
chemistri
biolog
immunodomin
antigen
need
guid
select
suitabl
express
system
sinc
outcom
may
differ
bacteria
yeast
mammalian
baculoviru
plant
express
system
differ
express
system
use
gener
recombin
protein
antigen
attempt
use
vaccinia
virusbas
ibv
vaccin
fail
produc
antigen
enough
induc
signific
antibodi
respons
mice
propos
use
vaccinia
virusbas
vaccin
may
hinder
issu
safeti
regard
vaccinia
viru
well
poor
replic
abil
avian
cell
anoth
studi
baculovirusbas
vector
use
express
korean
nephropathogen
strain
immun
chicken
vaccin
result
kidney
protect
follow
homolog
challeng
similarli
ibv
express
transgen
potato
control
cauliflow
mosaic
viru
promot
gene
success
could
use
design
foodbas
oral
ib
vaccin
use
poultri
improv
bacmam
viru
surfac
display
technolog
modifi
strategi
baculoviru
vector
use
recent
display
serotyp
subsequ
experiment
trial
vaccin
result
signific
humor
cellmedi
immun
respons
challeng
bird
shown
protect
compar
protect
obtain
bird
immun
commerci
inactiv
vaccin
system
rout
administr
deliveri
method
use
vaccin
may
affect
vaccineinduc
immun
respons
antigen
present
type
mhc
molecul
involv
result
respons
live
attenu
ib
vaccin
gain
wide
applic
via
inject
oral
aeronas
spray
kill
inactiv
dna
vaccin
peptidebas
vaccin
commonli
use
via
inject
rout
improv
method
use
deliv
recombin
protein
plasmid
dna
peptid
vaccin
exampl
ibvdna
vaccin
carri
nprotein
ibv
deliv
oral
use
attenu
salmonella
enterica
serovar
typhimurium
strain
interestingli
humor
mucos
immun
respons
shown
significantli
increas
follow
oral
intranas
immun
vaccin
chicken
protect
homolog
challeng
approach
record
success
use
lactococcu
lacti
bacteri
system
deliv
ibv
vaccin
approach
led
effici
mucos
immun
respons
viruslik
particl
vlp
new
focu
interest
vaccin
develop
technolog
util
immunogen
properti
live
viru
without
potenti
retain
pathogen
effect
vlpbase
ibv
vaccin
develop
use
ibvmand
ibvsgen
immun
mice
candid
vaccin
demonstr
high
level
cellmedi
immun
compar
result
obtain
use
live
attenu
viru
vaccin
similarli
chimer
vlp
vaccin
synthes
use
protein
avian
influenza
viru
fusion
protein
deriv
protein
cytoplasm
transmembran
domain
avian
influenza
na
protein
chimer
vaccin
induc
signific
antibodi
mice
chicken
neutral
antibodi
chicken
increas
secret
immun
mice
put
togeth
find
huge
potenti
vlpbase
vaccin
innov
candid
use
may
provid
deliveri
system
newer
ibv
vaccin
despit
spend
huge
amount
money
control
ib
outbreak
involv
classic
newli
emerg
viru
serotyp
constantli
report
increas
emerg
ibv
genotyp
lack
cross
protect
immun
augment
pace
interest
develop
novel
ibv
vaccin
though
live
attenu
vaccin
still
common
field
modif
exampl
revers
genet
technolog
use
reduc
effect
revers
virul
viral
vector
vaccin
potenti
facilit
effici
protein
antigen
product
evok
effect
immun
respons
howev
live
attenu
vaccin
effect
neutral
matern
antibodi
major
concern
regard
use
vectorbas
vaccin
sinc
vaccin
parent
poultri
breeder
practic
routin
doubt
newer
gener
vaccin
recombin
vector
dna
vaccin
plasmid
dna
vaccin
multiepitop
vaccin
may
stand
futur
altern
vaccin
potenti
deliv
numer
antigen
thu
produc
broadbas
antibodi
cellmedi
immun
respons
numer
serotyp
importantli
use
plasmid
dna
vaccin
circumv
effect
neutral
preexist
immun
mode
action
could
enhanc
deliveri
differ
rout
mucos
ovo
rout
well
use
novel
deliveri
method
nanoparticl
vlp
case
futur
ibv
vaccin
must
induc
broad
protect
differ
ibv
serotyp
overcom
matern
immun
meet
intern
safeti
regul
easier
appli
cost
effect
wider
accept
poultri
industri
cytotox
lymphocyt
jakstat
janu
kinasesign
transduc
activ
transcript
myeloid
differenti
primari
respons
gene
interferon
regulatori
factor
nf
nuclear
factor
nfkappab
mention
trade
name
commerci
product
paper
sole
purpos
provid
specif
inform
impli
recommend
endors
author
affili
institut
author
conflict
interest
